{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:42:29Z","timestamp":1790649749315,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CGC.NL","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"The Netherlands Cardio Vascular Research Initiative","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"FOP Italia","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"La Marat\u00f3-TV3","award":["202038"],"award-info":[{"award-number":["202038"]}]},{"name":"Chinese Scholarship Council","award":["no"],"award-info":[{"award-number":["no"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Angiogenesis, i.e., the formation of new blood vessels from pre-existing endothelial cell (EC)-lined vessels, is critical for tissue development and also contributes to neovascularization-related diseases, such as cancer. Vascular endothelial growth factor (VEGF) and bone morphogenetic proteins (BMPs) are among many secreted cytokines that regulate EC function. While several pharmacological anti-angiogenic agents have reached the clinic, further improvement is needed to increase clinical efficacy and to overcome acquired therapy resistance. More insights into the functional consequences of targeting specific pathways that modulate blood vessel formation may lead to new therapeutic approaches. Here, we synthesized and identified two macrocyclic small molecular compounds termed OD16 and OD29 that inhibit BMP type I receptor (BMPRI)-induced SMAD1\/5 phosphorylation and downstream gene expression in ECs. Of note, OD16 and OD29 demonstrated higher specificity against BMPRI activin receptor-like kinase 1\/2 (ALK1\/2) than the commonly used small molecule BMPRI kinase inhibitor LDN-193189. OD29, but not OD16, also potently inhibited VEGF-induced extracellular regulated kinase MAP kinase phosphorylation in ECs. In vitro, OD16 and OD29 exerted strong inhibition of BMP9 and VEGF-induced ECs migration, invasion and cord formation. Using Tg (fli:EGFP) zebrafish embryos, we found that OD16 and OD29 potently antagonized dorsal longitudinal anastomotic vessel (DLAV), intra segmental vessel (ISV), and subintestinal vessel (SIV) formation during embryonic development. Moreover, the MDA-MB-231 breast cancer cell-induced tumor angiogenesis in zebrafish embryos was significantly decreased by OD16 and OD29. Both macrocyclic compounds might provide a steppingstone for the development of novel anti-angiogenesis therapeutic agents.<\/jats:p>","DOI":"10.3390\/cancers13122951","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T10:30:25Z","timestamp":1623666625000},"page":"2951","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-1352","authenticated-orcid":false,"given":"Jin","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"},{"name":"Oncode Institute, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midory","family":"Thorikay","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"},{"name":"Oncode Institute, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van Dinther","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"},{"name":"Oncode Institute, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sanchez-Duffhues","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Caradec","sequence":"additional","affiliation":[{"name":"Oncodesign S.A., 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Benderitter","sequence":"additional","affiliation":[{"name":"Oncodesign S.A., 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hoflack","sequence":"additional","affiliation":[{"name":"Oncodesign S.A., 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-342X","authenticated-orcid":false,"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"},{"name":"Oncode Institute, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/00015458.2003.11679469","article-title":"Angiogenesis\u2014A New Goal in Peripheral Artery Occlusive Disease Therapy","volume":"103","year":"2003","journal-title":"Acta Chir. Belg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"585S","DOI":"10.1378\/chest.128.6_suppl.585S","article-title":"Transforming Growth Factor-\u03b2 Signal Transduction in Angiogenesis and Vascular Disorders","volume":"128","author":"Bertolino","year":"2005","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor Angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1096\/fj.201700193RR","article-title":"Role of bone morphogenetic proteins in sprouting angio-genesis: Differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence","volume":"31","author":"Benn","year":"2017","journal-title":"FASEB J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1684\/ecn.2009.0170","article-title":"VEGF-A: A critical regulator of blood vessel growth","volume":"20","author":"Ferrara","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"ref_7","first-page":"937","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"Coultas","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrm3176","article-title":"Molecular control of endothelial cell behaviour during blood vessel morphogenesis","volume":"12","author":"Herbert","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_9","first-page":"222","article-title":"Angiogenesis Inhibitors: Current Strategies and Future Prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA: A Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/127170","article-title":"Angiogenesis and Its Therapeutic Opportunities","volume":"2013","author":"Yoo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2009.05.001","article-title":"Emerging role of bone morphogenetic proteins in angiogenesis","volume":"20","author":"David","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33134","DOI":"10.1074\/jbc.M111.274100","article-title":"Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase Activation","volume":"286","author":"Gangopahyay","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tem.2014.05.003","article-title":"The role of BMPs in endothelial cell function and dysfunction","volume":"25","author":"Dyer","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells","volume":"109","author":"David","year":"2006","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2020.07.010","article-title":"BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1\/5\/ID1\/\u03b1-SMA pathway","volume":"147","author":"Li","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L","article-title":"Expression of ALK-1, a type 1 serine\/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development","volume":"209","author":"Roelen","year":"1997","journal-title":"Dev. Dyn."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1084\/jem.20091309","article-title":"Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis","volume":"207","author":"Cunha","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.CIR.0000033830.36431.46","article-title":"Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein\u2013Induced Activation of Endothelial Cells","volume":"106","author":"Valdimarsdottir","year":"2002","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25111","DOI":"10.1074\/jbc.M503328200","article-title":"Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors","volume":"280","author":"Brown","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.canlet.2015.10.036","article-title":"Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies","volume":"380","author":"Ye","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41388-020-1200-0","article-title":"BMP9 signaling promotes the normalization of tumor blood vessels","volume":"39","author":"Viallard","year":"2020","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","article-title":"Activin receptor-like kinase 1 modulates transforming growth factor-\u03b21 signaling in the regulation of angiogenesis","volume":"97","author":"Oh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.RES.0000095246.40391.3B","article-title":"Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arteriali-zation and vascular remodeling","volume":"93","author":"Seki","year":"2003","journal-title":"Circul. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","article-title":"ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway","volume":"22","author":"Prahst","year":"2012","journal-title":"Dev. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.cco.0000183672.15133.ab","article-title":"Update on angiogenesis inhibitors","volume":"17","author":"Zakarija","year":"2005","journal-title":"Curr. Opin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: Alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer","volume":"365","author":"Burger","year":"2011","journal-title":"New Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/cncr.32061","article-title":"A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma","volume":"125","author":"Voss","year":"2019","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jtho.2016.06.024","article-title":"A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207","volume":"11","author":"Chu","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Duffhues, G., Williams, E., Benderitter, P., Orlova, V., Van Wijhe, M., De Vinuesa, A.G., Kerr, G., Caradec, J., Lodder, K., and De Boer, H.C. (2019). Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells. JBMR Plus, 3.","DOI":"10.1002\/jbm4.10230"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4155\/fmc.12.93","article-title":"Macrocycles in new drug discovery","volume":"4","author":"Mallinson","year":"2012","journal-title":"Futur. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M111023200","article-title":"Identification and functional characterization of distinct critically important bone morpho-genetic protein-specific response elements in the Id1 promoter","volume":"277","author":"Korchynskyi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(98)00954-5","article-title":"The L45 loop in type I receptors for TGF-\u03b2 family members is a critical determinant in specifying Smad isoform activation","volume":"434","author":"Persson","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rosen, J.N., Sweeney, M.F., and Mably, J.D. (2009). Microinjection of Zebrafish Embryos to Analyze Gene Function. J. Vis. Exp.","DOI":"10.3791\/1115-v"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.24238\/13221-9-1-172","article-title":"Development of an ImageJ-based method for analysing the developing zebrafish vascu-lature","volume":"9","author":"Simms","year":"2017","journal-title":"Vasc. Cell"},{"key":"ref_39","first-page":"4266","article-title":"Venous-derived angioblasts generate organ-specific vessels during zebrafish embryonic development","volume":"142","author":"Hen","year":"2015","journal-title":"Development"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ren, J., Liu, S., Cui, C., and ten Dijke, P. (2017). Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish. J. Vis. Exp.","DOI":"10.3791\/55459-v"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1476-5381.2010.00871.x","article-title":"Intersegmental vessel formation in zebrafish: Requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists","volume":"161","author":"Cannon","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1242\/jcs.002949","article-title":"BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis","volume":"120","author":"Scharpfenecker","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1242\/jcs.112.20.3519","article-title":"Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation","volume":"112","author":"Ebisawa","year":"1999","journal-title":"J. Cell Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1091\/mbc.10.11.3801","article-title":"Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation","volume":"10","author":"Fujii","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18551","DOI":"10.1074\/jbc.M111.338103","article-title":"Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting","volume":"287","author":"Thorikay","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Alsamarah, A., LaCuran, A.E., Oelschlaeger, P., Hao, J., and Luo, Y. (2015). Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132221"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In Vivo Structure\u2212Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors","volume":"5","author":"Hao","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11523-009-0126-9","article-title":"Axitinib\u2014a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor","volume":"4","author":"Kelly","year":"2009","journal-title":"Target. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ncb2096","article-title":"Control of endothelial sprouting by a Tel\u2013CtBP complex","volume":"12","author":"Roukens","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_50","first-page":"1","article-title":"Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.devcel.2012.01.007","article-title":"Stalk Cell Phenotype Depends on Integration of Notch and Smad1\/5 Signaling Cascades","volume":"22","author":"Moya","year":"2012","journal-title":"Dev. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","article-title":"Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor","volume":"356","author":"Roskoski","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1074\/jbc.M114.604397","article-title":"Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin\/GDF8 Signaling and Promote Functional Myoblast Differentiation","volume":"290","author":"Horbelt","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Draut, H., Rehm, T., Begemann, G., and Schobert, R. (2017). Antiangiogenic and Toxic Effects of Genistein, Usnic Acid, and Their Copper Complexes in Zebrafish Embryos at Different Developmental Stages. Chem. Biodivers., 14.","DOI":"10.1002\/cbdv.201600302"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Morikawa, M., Derynck, R., and Miyazono, K. (2016). TGF-\u03b2 and the TGF-\u03b2 family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol., 8.","DOI":"10.1101\/cshperspect.a021873"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ceb.2012.02.002","article-title":"VEGF signaling inside vascular endothelial cells and beyond","volume":"24","author":"Eichmann","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.3892\/mmr.2017.7730","article-title":"Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT\/FAK signal axis","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000209968.66606.10","article-title":"IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain","volume":"98","author":"Bodnar","year":"2006","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/ATVBAHA.116.308422","article-title":"Alk2\/ACVR1 and Alk3\/BMPR1A Provide Essential Function for Bone Morphogenetic Protein\u2013Induced Retinal Angiogenesis","volume":"37","author":"Lee","year":"2017","journal-title":"Arter. Thromb. Vasc. Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/12\/2951\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:13:39Z","timestamp":1760163219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/12\/2951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["cancers13122951"],"URL":"https:\/\/doi.org\/10.3390\/cancers13122951","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]}}}